Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03397654
What this trial is testing

Study of Pembrolizumab Following TACE in Primary Liver Carcinoma

Who this might be right for
Primary Liver Carcinoma
Imperial College London 26
Not applicableUnknownNCT05685524
What this trial is testing

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

Who this might be right for
Cancer
Wuhan Ammunition Life-tech Co., Ltd 3,000
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Testing effectiveness (Phase 2)Study completedNCT00877071
What this trial is testing

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed

Who this might be right for
Hepatocellular Carcinoma
University of Pittsburgh 2
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Not applicableNot Yet RecruitingNCT07704216
What this trial is testing

Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 150
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Early research (Phase 1)Looking for participantsNCT07390838
What this trial is testing

SH009 Injection in Patients With Advanced Solid Tumors.

Who this might be right for
Liver Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)Head and Neck Cancer Squamous Cell Carcinoma+4 more
Nanjing Sanhome Pharmaceutical, Co., Ltd. 150
Not applicableLooking for participantsNCT00034216
What this trial is testing

Collection of Blood From Patients With Cancer

Who this might be right for
Prostate CancerBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 1,750
Large-scale testing (Phase 3)Active Not RecruitingNCT03383458
What this trial is testing

Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Bristol-Myers Squibb 545
Not applicableUnknownNCT04445532
What this trial is testing

Hepatobiliary Tumors Tissue Samples Acquisition

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaGallbladder Cancer+5 more
Peking Union Medical College Hospital 450
Testing effectiveness (Phase 2)Ended earlyNCT00787787
What this trial is testing

Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
University of Washington 41
Not applicableApproved For MarketingNCT00906984
What this trial is testing

TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
University of California, Irvine
Not applicableStudy completedNCT03213314
What this trial is testing

HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

Who this might be right for
Liver CancerSurgeryLiver Regeneration+1 more
University of Edinburgh 149
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Post-approval studies (Phase 4)Not Yet RecruitingNCT07734766
What this trial is testing

Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery

Who this might be right for
Hepato Cellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 45
Early research (Phase 1)Study completedNCT00987766
What this trial is testing

Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+3 more
Vanderbilt-Ingram Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT05337137
What this trial is testing

Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Bristol-Myers Squibb 83
Large-scale testing (Phase 3)Study completedNCT00003424
What this trial is testing

Tamoxifen in Treating Patients With Primary Liver Cancer

Who this might be right for
Liver Cancer
National Medical Research Council (NMRC), Singapore 300
Not applicableStudy completedNCT00683631
What this trial is testing

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Louisville 183
Next Page